The technology relates to an antibody for the treatment of candidiasis that is able to block/mask CaHgt1p and thereby enhance phagocytosis of candida. This represents a completely novel way of fungal treatment.
This technology provides a biocatalytic method for the regioselective monoacylation of
phenols or aminophenols serving as acyl acceptors in the presence of acyl donor molecules
of the formula R2-C(=O)-R3 and acyl transferase (ATase) enzymes as catalysts. The produced
phenols can be used in different markets, such as cosmetics, aroma (natural), industrial
enzymes (5 billion US$ p.a.), biocatalysis, pharmaceutical industry, agricultural chemistry,
biological pesticides.
During laser beam welding the focus position of the laser beam should be on the workpiece surface. With the present invention, this focus position can be detected in relation to the workpiece. Thus, the process can be set up quickly, but also the focus shift could be compensated. Also, this method can prepare the basis for calibrating scanner optics.
The assay detects lgM antibodies with high sensitivity and specificity and thus provides a means for the early serological diagnosis of flavivirus infections. lt is based on an lgM-capture format and highly purified recombinant viral antigens, allowing the differentiation between infections with antigenically closely related flaviviruses like dengue and Zika viruses. The lgM-capture format is robust, can be easily standardized and readily adapted to existing diagnostic systems for antibody detection.
Monitoring of fish swarms in muddy waters or during the night with new procedure for operating and reading out of multi static sonars.
The invention offers an autoantibody set that can be used as a diagnostic tool for diagnosis and stratification of colorectal cancer patients.